Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AMIX NASDAQ:CODX NASDAQ:FEMY NASDAQ:ZJYL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMIXAutonomix Medical$6.76+5.1%$7.61$4.20▼$55.44$3.49M-1.3217,587 shs7,106 shsCODXCo-Diagnostics$2.73-8.7%$3.67$1.26▼$46.50$11.02M2.84686,354 shs505,457 shsFEMYFemasys$4.08-2.2%$6.23$3.50▼$22.20$12.59M-2.1356,168 shs42,643 shsZJYLJin Medical International$1.98+1.0%$2.34$1.64▼$17.18$15.34M7.3424,840 shs7,539 shsDon't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMIXAutonomix Medical+5.13%+15.75%-21.49%-15.27%-77.17%CODXCo-Diagnostics-8.70%-8.39%-51.51%+92.25%-68.29%FEMYFemasys-2.16%+9.09%+1,231.59%-48.05%-78.16%ZJYLJin Medical International+1.02%-11.21%-19.84%-1.49%-84.70%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMIXAutonomix Medical$6.76+5.1%$7.61$4.20▼$55.44$3.49M-1.3217,587 shs7,106 shsCODXCo-Diagnostics$2.73-8.7%$3.67$1.26▼$46.50$11.02M2.84686,354 shs505,457 shsFEMYFemasys$4.08-2.2%$6.23$3.50▼$22.20$12.59M-2.1356,168 shs42,643 shsZJYLJin Medical International$1.98+1.0%$2.34$1.64▼$17.18$15.34M7.3424,840 shs7,539 shsDon't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMIXAutonomix Medical+5.13%+15.75%-21.49%-15.27%-77.17%CODXCo-Diagnostics-8.70%-8.39%-51.51%+92.25%-68.29%FEMYFemasys-2.16%+9.09%+1,231.59%-48.05%-78.16%ZJYLJin Medical International+1.02%-11.21%-19.84%-1.49%-84.70%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMIXAutonomix Medical 2.00Hold$42.00521.30% UpsideCODXCo-Diagnostics 2.00Hold$67.502,372.53% UpsideFEMYFemasys 2.50Moderate Buy$106.672,514.38% UpsideZJYLJin Medical International 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest AMIX, ZJYL, FEMY, and CODX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/29/2026ZJYLJin Medical International Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D+) ➝ Sell (D)6/23/2026AMIXAutonomix Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E) ➝ Sell (E+)6/11/2026CODXCo-Diagnostics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)6/3/2026AMIXAutonomix Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (E+) ➝ Sell (E)6/3/2026FEMYFemasys Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)6/2/2026AMIXAutonomix Medical Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold5/26/2026CODXCo-Diagnostics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/18/2026AMIXAutonomix Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E) ➝ Sell (E+)5/18/2026FEMYFemasys Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)5/4/2026AMIXAutonomix Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (E+) ➝ Sell (E)5/1/2026FEMYFemasys Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)(Data available from 7/7/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMIXAutonomix MedicalN/AN/AN/AN/A$10.85 per shareN/ACODXCo-Diagnostics$620K16.25N/AN/A$9.14 per share0.30FEMYFemasys$2.29M5.38N/AN/A$2.01 per share2.03ZJYLJin Medical International$20.69M0.75$0.19 per share10.70$3.78 per share0.52Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMIXAutonomix Medical-$16.72M-$74.58N/AN/AN/AN/A-239.36%-192.46%8/12/2026 (Estimated)CODXCo-Diagnostics-$46.90M-$15.77N/AN/AN/A-6,760.63%-164.92%-141.15%8/14/2026 (Estimated)FEMYFemasys-$18.63M-$5.40N/AN/AN/A-521.97%-258.08%-73.72%8/12/2026 (Estimated)ZJYLJin Medical International$1.19MN/AN/AN/AN/AN/AN/AN/AN/ALatest AMIX, ZJYL, FEMY, and CODX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2026Q1 2026CODXCo-Diagnostics-$3.75-$4.06-$0.31-$4.06$0.13 million$0.15 million5/8/2026Q1 2026FEMYFemasys-$1.3334$0.0980+$1.4314N/A$0.77 million$0.42 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthAMIXAutonomix MedicalN/AN/AN/AN/AN/ACODXCo-DiagnosticsN/AN/AN/AN/AN/AFEMYFemasysN/AN/AN/AN/AN/AZJYLJin Medical InternationalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMIXAutonomix MedicalN/A4.454.45CODXCo-DiagnosticsN/A2.282.09FEMYFemasys0.533.911.98ZJYLJin Medical InternationalN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMIXAutonomix Medical10.78%CODXCo-Diagnostics14.99%FEMYFemasys65.27%ZJYLJin Medical InternationalN/AInsider OwnershipCompanyInsider OwnershipAMIXAutonomix Medical6.20%CODXCo-Diagnostics5.40%FEMYFemasys7.75%ZJYLJin Medical InternationalN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMIXAutonomix Medical1540,000509,000N/ACODXCo-Diagnostics1003.69 million3.49 millionOptionableFEMYFemasys303.02 million2.79 millionNot OptionableZJYLJin Medical International2457.83 millionN/ANot OptionableAMIX, ZJYL, FEMY, and CODX HeadlinesRecent News About These CompaniesJin Medical International Ltd. (NASDAQ:ZJYL) Short Interest UpdateJuly 3, 2026 | americanbankingnews.comJin Medical International Ltd - Ordinary Shares - Class AJuly 1, 2026 | money.usnews.comJin Medical Plans Major VIE Acquisition and Governance Restructuring Ahead of July 2026 EGMJune 29, 2026 | tipranks.comReviewing Jin Medical International (NASDAQ:ZJYL) & Haemonetics (NYSE:HAE)June 27, 2026 | americanbankingnews.comJin Medical International Replaces Audit Alliance With Enrome as Independent AuditorJune 4, 2026 | tipranks.comJin Medical Regains Nasdaq Bid-Price Compliance After Reverse Share SplitApril 10, 2026 | theglobeandmail.comJin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price RequirementApril 7, 2026 | prnewswire.comJin Medical International Ltd. Announces 1-for-20 Share Combination as Part of Strategic Nasdaq Compliance InitiativeMarch 11, 2026 | prnewswire.comJin Medical Shareholders Approve Dual-Class Structure and Conditional Reverse SplitsFebruary 7, 2026 | theglobeandmail.comJin Medical CEO Fireside ChatFebruary 5, 2026 | prnewswire.comJin Medical to Host February 1 Fireside Chat as It Revamps Corporate WebsiteJanuary 28, 2026 | tipranks.comJin Medical International Ltd. To Host Management Fireside ChatJanuary 26, 2026 | prnewswire.comJin Medical Sets April Launch for High-Capacity Chuzhou Mobility Device PlantJanuary 22, 2026 | tipranks.comJin Medical Announces the Official Commencement Date of Chuzhou FacilityJanuary 22, 2026 | prnewswire.comJin Medical International Ltd. Management Plans For Fireside ChatJanuary 21, 2026 | finance.yahoo.comJin Medical International Ltd. to Host Fireside Chat on Strategic Priorities and Capital Structure on February 1, 2026January 21, 2026 | quiverquant.comQJin Medical Calls January 30 EGM to Restructure Share Capital and Adopt New Equity PlanJanuary 8, 2026 | tipranks.comJin Medical International (NASDAQ:ZJYL) Trading Down 4.6% – Should You Sell?November 22, 2025 | defenseworld.netDAre Jin Medical International Ltd.'s (NASDAQ:ZJYL) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?October 5, 2025 | uk.finance.yahoo.comJin Medical International (NASDAQ:ZJYL) Will Want To Turn Around Its Return TrendsAugust 25, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeAMIX, ZJYL, FEMY, and CODX Company DescriptionsAutonomix Medical NASDAQ:AMIX$6.76 +0.33 (+5.13%) Closing price 07/6/2026 04:00 PM EasternExtended Trading$6.69 -0.07 (-0.98%) As of 07/6/2026 06:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.Co-Diagnostics NASDAQ:CODX$2.73 -0.26 (-8.70%) Closing price 07/6/2026 04:00 PM EasternExtended Trading$2.79 +0.06 (+2.16%) As of 07/6/2026 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.Femasys NASDAQ:FEMY$4.08 -0.09 (-2.16%) Closing price 07/6/2026 04:00 PM EasternExtended Trading$4.08 +0.00 (+0.12%) As of 07/6/2026 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.Jin Medical International NASDAQ:ZJYL$1.98 +0.02 (+1.02%) Closing price 07/6/2026 04:00 PM EasternExtended Trading$2.04 +0.06 (+2.83%) As of 07/6/2026 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Flash Crash or Cash? The AI Hardware Reset Investors Can’t Ignore KBR Insiders Are Buying While the Market Misreads Its Spinoff Doug Casey Calls AI a Super Bubble, Bets on Energy, Gold Miners and Grains Contrarian Alert: 5 Downgraded Stocks That May Reward Long-Term Investors This Edge AI Stock Just Got a Huge Vote of Confidence From Wall Street AI Is Selling Off, But These 5 Stocks Could Benefit Next MarketBeat Week in Review – 06/29 - 07/03 Analysts Just Raised Price Targets On These 3 Semiconductor Equipment Stocks Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
